• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>FileNet Corporation

FileNet Corporation

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Steel Partners and Handy & Harman Sign Definitive Agreement For Steel Partners To Acquire Remaining Shares of Handy & Harman It Does Not Own

    Steel Partners and Handy & Harman Sign Definitive Agreement For Steel Partners To Acquire Remaining Shares of Handy & Harman It Does Not Own

  2. UPDATE: How to ignore politics and get yourself the perfect health insurance

    UPDATE: How to ignore politics and get yourself the perfect health insurance

  3. Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming July 5th Deadline in the Class Action Lawsuit Against Sunrun Inc.

    Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming July 5th Deadline in the Class Action Lawsuit Against Sunrun Inc.

  4. July 5th Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming Deadline in the Class Action Lawsuit Against Vince Holdings Corp.

    July 5th Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming Deadline in the Class Action Lawsuit Against Vince Holdings Corp.

  5. UPDATE: How to ignore politics and get yourself the perfect health insurance

    UPDATE: How to ignore politics and get yourself the perfect health insurance

  6. UPDATE: Don't make these common mistakes when applying for college financial aid

    UPDATE: Don't make these common mistakes when applying for college financial aid

  7. UPDATE: J.K. Rowling's first spell -- becoming a billionaire by masquerading as a man

    UPDATE: J.K. Rowling's first spell -- becoming a billionaire by masquerading as a man

  8. Judge Denies Qualcomm Motion to Dismiss FTC's Competition Lawsuit

    Judge Denies Qualcomm Motion to Dismiss FTC's Competition Lawsuit

  9. Alder BioPharma stock drops nearly 20% as investors shrug off positive migraine drug results

    Alder BioPharma stock drops nearly 20% as investors shrug off positive migraine drug results

  10. Slayback Pharma Appoints Patrick McIntosh as Head of Commercial Operations

    Slayback Pharma Appoints Patrick McIntosh as Head of Commercial Operations

12345

©2017 Morningstar Advisor. All right reserved.